• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The effect of piperacillin dose on elimination kinetics in renal impairment.

作者信息

Aronoff G R, Sloan R S, Brier M E, Luft F C

出版信息

Eur J Clin Pharmacol. 1983;24(4):543-7. doi: 10.1007/BF00609901.

DOI:10.1007/BF00609901
PMID:6222908
Abstract

The effect of drug dose on piperacillin elimination kinetics was examined in 27 adult subjects with varying renal function. Piperacillin, 15 mg/kg or 60 mg/kg, was given by bolus intravenous injection. The elimination half-life (t1/2) increased five-fold and plasma clearance (Clp) decreased by 80% in patients with renal failure. Both parameters were dose dependent in patients with normal renal function, but not in patients with renal insufficiency. Piperacillin dose dependent elimination is due primarily to capacity limited renal excretion.

摘要

相似文献

1
The effect of piperacillin dose on elimination kinetics in renal impairment.
Eur J Clin Pharmacol. 1983;24(4):543-7. doi: 10.1007/BF00609901.
2
Pharmacokinetics of piperacillin in subjects with various degrees of renal function.哌拉西林在不同程度肾功能受试者中的药代动力学。
Antimicrob Agents Chemother. 1983 Jun;23(6):881-7. doi: 10.1128/AAC.23.6.881.
3
Mezlocillin pharmacokinetics after single intravenous doses to patients with varying degrees of renal function.不同程度肾功能患者单次静脉注射美洛西林后的药代动力学。
Antimicrob Agents Chemother. 1980 Apr;17(4):599-607. doi: 10.1128/AAC.17.4.599.
4
Pharmacokinetics of piperacillin, tazobactam and its metabolite in renal impairment.
Int J Clin Pharmacol Ther. 1996 Nov;34(11):482-8.
5
Piperacillin pharmacokinetics in pediatric patients.哌拉西林在儿科患者中的药代动力学。
Antimicrob Agents Chemother. 1982 Sep;22(3):442-7. doi: 10.1128/AAC.22.3.442.
6
Overview of acylureidopenicillin pharmacokinetics.酰脲类青霉素的药代动力学概述。
Scand J Infect Dis Suppl. 1981;29:33-48.
7
Review of the pharmacokinetics and dose dependency of azlocillin in normal subjects and patients with renal insufficiency.阿洛西林在正常受试者和肾功能不全患者中的药代动力学及剂量依赖性综述。
J Antimicrob Chemother. 1983 May;11 Suppl B:101-14. doi: 10.1093/jac/11.suppl_b.101.
8
Dose dependence of piperacillin pharmacokinetics.
Chemotherapy. 1982;28(3):153-9. doi: 10.1159/000238070.
9
The pharmacokinetics of temocillin in patients with normal and impaired renal function.替莫西林在肾功能正常和受损患者中的药代动力学。
J Antimicrob Chemother. 1983 Apr;11(4):349-56. doi: 10.1093/jac/11.4.349.
10
Pharmacokinetics of intravenous piperacillin in patients undergoing chronic hemodialysis.慢性血液透析患者静脉注射哌拉西林的药代动力学
Antimicrob Agents Chemother. 1979 Dec;16(6):788-91. doi: 10.1128/AAC.16.6.788.

引用本文的文献

1
Population Pharmacokinetics of Piperacillin in Sepsis Patients: Should Alternative Dosing Strategies Be Considered?脓毒症患者哌拉西林的群体药代动力学:是否应考虑替代给药策略?
Antimicrob Agents Chemother. 2018 Apr 26;62(5). doi: 10.1128/AAC.02306-17. Print 2018 May.
2
Population pharmacokinetics of piperacillin at two dose levels: influence of nonlinear pharmacokinetics on the pharmacodynamic profile.两种剂量水平哌拉西林的群体药代动力学:非线性药代动力学对药效学特征的影响。
Antimicrob Agents Chemother. 2012 Nov;56(11):5715-23. doi: 10.1128/AAC.00937-12. Epub 2012 Aug 20.
3
Kidney failure related to broad-spectrum antibiotics in critically ill patients: secondary end point results from a 1200 patient randomised trial.

本文引用的文献

1
Overview of acylureidopenicillin pharmacokinetics.酰脲类青霉素的药代动力学概述。
Scand J Infect Dis Suppl. 1981;29:33-48.
2
Piperacillin pharmacokinetics in subjects with chronic renal failure.哌拉西林在慢性肾衰竭患者中的药代动力学。
Antimicrob Agents Chemother. 1981 Mar;19(3):450-3. doi: 10.1128/AAC.19.3.450.
3
Pharmacokinetics of piperacillin in renal failure.哌拉西林在肾衰竭患者中的药代动力学
危重症患者中与广谱抗生素相关的肾衰竭:一项纳入1200例患者的随机试验的次要终点结果
BMJ Open. 2012 Mar 11;2(2):e000635. doi: 10.1136/bmjopen-2011-000635. Print 2012.
4
Nonlinear pharmacokinetics of piperacillin in healthy volunteers--implications for optimal dosage regimens.哌拉西林在健康志愿者中的非线性药代动力学——对最佳剂量方案的影响。
Br J Clin Pharmacol. 2010 Nov;70(5):682-93. doi: 10.1111/j.1365-2125.2010.03750.x.
5
Identification of optimal renal dosage adjustments for traditional and extended-infusion piperacillin-tazobactam dosing regimens in hospitalized patients.鉴定传统和延长输注哌拉西林他唑巴坦给药方案在住院患者中的最佳肾脏剂量调整。
Antimicrob Agents Chemother. 2010 Jan;54(1):460-5. doi: 10.1128/AAC.00296-09. Epub 2009 Oct 26.
6
Pharmacokinetics of intravenous piperacillin administration in patients undergoing on-line hemodiafiltration.接受在线血液透析滤过治疗的患者静脉注射哌拉西林的药代动力学
Antimicrob Agents Chemother. 2009 Aug;53(8):3266-8. doi: 10.1128/AAC.01670-08. Epub 2009 May 18.
7
Piperacillin and tazobactam exhibit linear pharmacokinetics after multiple standard clinical doses.哌拉西林和他唑巴坦在多次标准临床剂量给药后呈现线性药代动力学。
Antimicrob Agents Chemother. 1999 Jun;43(6):1465-8. doi: 10.1128/AAC.43.6.1465.
8
Drug dosage in patients during continuous renal replacement therapy. Pharmacokinetic and therapeutic considerations.持续肾脏替代治疗患者的药物剂量。药代动力学及治疗方面的考量。
Clin Pharmacokinet. 1993 May;24(5):362-79. doi: 10.2165/00003088-199324050-00002.
9
Single-dose pharmacokinetics of piperacillin and tazobactam in infants and children.哌拉西林和他唑巴坦在婴幼儿及儿童中的单剂量药代动力学
Antimicrob Agents Chemother. 1994 Dec;38(12):2817-26. doi: 10.1128/AAC.38.12.2817.
10
Piperacillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.哌拉西林。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1984 Nov;28(5):375-425. doi: 10.2165/00003495-198428050-00002.
Med J Aust. 1981 Jan 10;1(1):35-6. doi: 10.5694/j.1326-5377.1981.tb135286.x.
4
Biliary concentrations of piperacillin in patients undergoing cholecystectomy.胆囊切除术患者胆汁中哌拉西林的浓度。
Antimicrob Agents Chemother. 1981 Feb;19(2):309-11. doi: 10.1128/AAC.19.2.309.
5
Pharmacokinetics of piperacillin in patients with moderate renal failure and in patients undergoing hemodialysis.哌拉西林在中度肾衰竭患者及接受血液透析患者中的药代动力学。
Antimicrob Agents Chemother. 1981 Feb;19(2):279-83. doi: 10.1128/AAC.19.2.279.
6
Dose dependence of piperacillin pharmacokinetics.
Chemotherapy. 1982;28(3):153-9. doi: 10.1159/000238070.
7
Mezlocillin dose dependent elimination kinetics in renal impairment.肾功能不全时美洛西林的剂量依赖性消除动力学
Eur J Clin Pharmacol. 1982;21(6):505-9. doi: 10.1007/BF00542046.
8
In vitro and in vivo antibacterial activity of T-1220, a new semisynthetic penicillin.新型半合成青霉素T-1220的体外及体内抗菌活性
Antimicrob Agents Chemother. 1977 Oct;12(4):455-60. doi: 10.1128/AAC.12.4.455.
9
Piperacillin: human pharmacokinetics after intravenous and intramuscular administration.哌拉西林:静脉注射和肌肉注射后的人体药代动力学
Antimicrob Agents Chemother. 1978 Dec;14(6):829-37. doi: 10.1128/AAC.14.6.829.
10
Piperacillin, a new penicillin active against many bacteria resistant to other penicillins.哌拉西林,一种新型青霉素,对许多耐其他青霉素的细菌有活性。
Antimicrob Agents Chemother. 1978 Mar;13(3):358-67. doi: 10.1128/AAC.13.3.358.